New research suggests that individuals who discontinue popular slimming jabs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who halt traditional lifestyle regimens.
Findings released in a prominent medical journal shows that while overweight people frequently drop about a fifth of their body weight while on the medication, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"People purchasing these drugs must be cognizant of the danger of fast weight regain when the treatment ends," stated lead investigator Dr. Susan Jebb.
That rate of regain suggests a reversion to starting weight in about a year and a half.
Weighing Therapies
The analysis, which reviewed 37 of studies involving thousands of patients, compared the outcomes of these new drugs with conventional dieting.
The team point out that individuals who lose weight through diet and exercise typically see a slower weight regain—around 100 grams monthly—after stopping.
Understanding the Rapid Regain
Doctors believe the way of the jabs accounts for the heightened regain.
These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone levels far above than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making overeating much more probable."
A Lifelong Issue?
Health authorities advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the high risk of relapse, the treatment should be considered long-term.
This perspective is supported by pharmaceutical companies, who state that the results "highlight the long-term character of excess weight," similar to managing conditions like hypertension.
User Experiences
People who have discontinued the medication report a intense return of appetite.
"It felt as if a switch flipping and I was suddenly starving," described an individual.
This challenge is exacerbated if patients have not adopted sustainable dietary or behavioural modifications during therapy.
Significant Interest
Figures indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is higher among women than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Finally, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a magic fix and long-term success hinges on combined behavioural management.
